Fresh From the Bench: Latest Federal Circuit Court Cases
Contributed by Schwabe Williamson & Wyatt. Originally published on Patexia; republished here as part of the LexDana archive.
CASE OF THE WEEK
In re: Nitro Fluids L.L.C., Appeal No. 2020-142 (Fed. Cir. Oct. 28, 2020)
In the Court’s only precedential patent opinion this week, the Federal Circuit granted a mandamus petition vacating the district court’s denial of a convenience transfer under 28 U.S.C. § 1404(a). Plaintiff Cameron International Corporation had initially brought suit in 2018 against appellant Nitro Fluids in the Southern District of Texas, alleging infringement of fracking-related patents, and then sued Nitro on related patents in the Western District of Texas in February 2020, alleging infringement by the same accused products. When Nitro moved to transfer the second action to the Southern District of Texas under the first-to-file rule, the district court agreed that the cases involved substantially similar issues such that the first-to-file rule would typically apply. However, notwithstanding that both parties were headquartered in the Southern District and that several of the Fifth Circuit’s § 1404(a) factors favored transfer, the district court found that because Nitro had not demonstrated that a balance of the factors favored transfer, compelling circumstances existed to avoid application of the first-to-file rule.
Read More.
Edited by: Scott D. Eads and Nika Aldrich, Schwabe Williamson & Wyatt
Contributor: Jason Wrubleski
More insights
Federal Circuit Affirms Invalidation of Patent for Lack of Enablement of Claims Directed to a Method of Treating a Patient with a Unit Dosage in Wyeth Llc v Astrazeneca Pharmaceuticals Lp
Written by : Eric Furman, Ph.D. and Ashley C. Morales Key Takeaway: Federal Circuit invalidates patent claims directed to a method for treating non-small cell lung cancer through administration of “a unit dosage” of an irreversible epidermal…
When About Becomes Indefinite Federal Circuit Provides Guidance for Life Science Patent Applications Regarding Limits of Approximation in Enviro Tech v Safe Foods
Written by : Jason J. Jardine and Kenneth O. Aruda, Ph.D. Key Takeaway: The term “about” remains useful in biotech and pharmaceutical claims, but only if the patent provides objective guidance about what the term means. Absent that guidance,…
When Any Patent Means No Patent Federal Circuit Reverses Non Specific Verdict
Written by : Brian C. Barnes and Sophia F. Zahn OLLNOVA TECHNOLOGIES LTD. v. ECOBEE TECHNOLOGIES ULC [OPINION] Before Chen , Cunningham, and Stark. Appeal from the United States District Court for the Eastern District of Texas. Summary : A verdict form…